Skip to main content
. Author manuscript; available in PMC: 2015 Jan 22.
Published in final edited form as: Int J Cancer Res. 2013;9(2):36–53. doi: 10.3923/ijcr.2013.36.53

Fig. 3.

Fig. 3

GZL decreases the expression of NF-κB mediators in HT-29 cells. GZL suppresses NF-κB activation in comparison with the negative control (N) and the positive control rocaglamide (R), in the presence of TNFα treatment. (A) A decrease in NF-κB p65 and p50 subunits was detected at different concentrations of GZL. (B) IKKα and IKKβ were downregulated in treated HT-29 cells. β-Actin expression was used as an internal control to establish equivalent protein loading.